Literature DB >> 8297539

Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.

R R Williams1, S C Hunt, P N Hopkins, L L Wu, S J Hasstedt, T D Berry, G K Barlow, B M Stults, M C Schumacher, E H Ludwig.   

Abstract

The genetic and environmental determinants of hypertension, lipid abnormalities, and coronary artery disease (CAD) have been studied for 15 years in Utah in population-based multigenerational pedigrees (2500 subjects among 98 pedigrees), twin pairs (74 monozygous and 78 dizygous), hypertensive siblings (131 sibships), siblings with CAD before age 55 (45 sibships), and anecdotally ascertained pedigrees with type II diabetes (271 subjects among 16 pedigrees), lipoprotein lipase deficiency (106 subjects in a single pedigree), and familial hypercholesterolemia (502 heterozygotes among 50 pedigrees). Estimates of heritability ranged from 20 to 75% for blood pressures and blood lipids. A strong positive family history predicts a future occurrence of hypertension (relative risk [RR] = 3.8) and CAD (RR = 12.7). Segregating single-gene effects were found for several 'intermediate phenotypes' associated with hypertension (erythrocyte sodium-lithium countertransport, intraerythrocytic sodium, a relative fat pattern, total urinary kallikrein excretion, and fasting insulin levels). Strong single-gene effects in segregation analysis were also found for low-density lipoprotein (LDL) cholesterol, lipoprotein (a) (Lp[a]), low high-density lipoprotein (HDL) cholesterol, and high apolipoprotein (apo) B. Deoxyribonucleic acid (DNA) markers of lipid abnormalities or hypertension have included LDL-receptor defects, lipoprotein lipase deficiency, high Lp(a), familial defective apo B, decreased quantitative levels of apo B, apo E phenotype, angiotensinogen, and 'glucocorticoid remediable aldosteronism (GRA) hypertension.' Also tested in Utah studies, but not found to be DNA markers for hypertension, were the genetic loci for the structural genes for renin and angiotensin-converting enzyme, and the sodium antiport system. In addition, important gene-gene interactions (LDL receptor with apo E2) and gene-environment interactions (kallikrein with potassium intake) were found.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8297539     DOI: 10.1093/ajh/6.11.319s

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

1.  Coronary risk correlates with cerebral amyloid deposition.

Authors:  Bruce R Reed; Natalie L Marchant; William J Jagust; Charles C DeCarli; Wendy Mack; Helena C Chui
Journal:  Neurobiol Aging       Date:  2011-11-10       Impact factor: 4.673

2.  Complex trait genetics: new methods yield a result for essential hypertension.

Authors:  D T O'Connor; M T Kailasam; R J Parmer
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

3.  The effects of age, gender, and family history on blood pressure of normotensive college students.

Authors:  J J Sherman; M J Cordova; J F Wilson; J A McCubbin
Journal:  J Behav Med       Date:  1996-12

4.  Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22.

Authors:  D A Wu; X Bu; C H Warden; D D Shen; C Y Jeng; W H Sheu; M M Fuh; T Katsuya; V J Dzau; G M Reaven; A J Lusis; J I Rotter; Y D Chen
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

Review 5.  The role of beta(2)-adrenergic receptor variation in human hypertension.

Authors:  M S Bray; E Boerwinkle
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

6.  Association between family risk of stroke and myocardial infarction with prevalent risk factors and coexisting diseases.

Authors:  Richard E Kennedy; George Howard; Rodney C Go; Peter M Rothwell; Hemant K Tiwari; Rui Feng; Leslie A McClure; Ronald J Prineas; Amitava Banerjee; Donna K Arnett
Journal:  Stroke       Date:  2012-02-09       Impact factor: 7.914

7.  A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.

Authors:  S H Juo; S J Bredie; L A Kiemeney; P N Demacker; A F Stalenhoef
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

8.  Familial aggregation of insulin resistance and cardiovascular risk factors in hypertension.

Authors:  Annaswamy Raji; Jonathan S Williams; Paul N Hopkins; Donald C Simonson; Gordon H Williams
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

Review 9.  Genes for blood pressure: an opportunity to understand hypertension.

Authors:  Georg B Ehret; Mark J Caulfield
Journal:  Eur Heart J       Date:  2013-01-09       Impact factor: 29.983

10.  Association of the angiotensinogen gene polymorphism with atherosclerosis and its risk traits in the Saudi population.

Authors:  Mohammed Al-Najai; Paul Muiya; Asma I Tahir; Samar Elhawari; Daisy Gueco; Editha Andres; Nejat Mazhar; Nada Altassan; Maie Alshahid; Nduna Dzimiri
Journal:  BMC Cardiovasc Disord       Date:  2013-03-11       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.